The principal actors in the scandalous procurement processes for the supply of Anti-Snake Venom (West Africa Polyvalent Serum) have lied to President Nana Addo Dankwa Akufo-Addo about the deal, which has become an albatross around the neck of the country’s Health Minister, Mr. Kwaku Agyeman-Manu.
At a Cabinet meeting that the President wanted to be on top of his brief, following the exposure that the Ministry of Health (MoH) was twisting the arms of local Ghanaian companies for Indian interests, the President was told that the quotations of the Ghanaian companies that were legitimately left in the bid process after the Indian interests were disqualified by the Public Procurement Authority (PPA) were high.
The story at Cabinet was totally false; rather, the true story is that the powerful forces at the helm of the nation’s health sector want their favourite Pharmanova Export PVT and Pharmanova Ghana Limited to be the suppliers of the anti-snake serum, although PPA has boldly exposedthe dirty underhand dealings on the part of the two companies during the bid process.
It is not too clear when the said Cabinet meeting was held.
It is instructive to know that the PPA ordered the MoH to overturn and duly annul the contract to Pharmanova PVT of India to supply the anti-snake serum.
Two Ghanaian companies,Kinapharma Limited and AS-TESCO Investment Company Limited, were therefore left to do the race, but the MoH had other plans to scuttle the supply of the anti-snake serum by either of the two local companies.
Kinapharma Limited quoted GHC20, 000,000.00 while AS-TESCO Investment Company Limited quoted GHC20, 750,000.00 which were far below the GHC23, 335,000.00 by the MoH’s darling Pharmanova Ghana Limited.
The Inquisitor has been told of a lavish party that Pharmanova allegedly threw for top government officials in far away India not long ago, when they attended an Expo event in that country, something the President may not be aware of (Full Story In Offing).
At the said Cabinet meeting that the President was deceived, he was told that the quotations of Kinapharma and AS-TESCO Investment Company Limited were far above what the ministry had budgeted for the all-important serum needed to save lives.
The MoH had approved a budget of GHC23, 500.000.00 in its procurement plan for the supply of some 50,000 vials of the anti-snake venom.
It stands to reason that the two Ghanaian companies’ quotations were reasonable as compared to that Pharmanova Export PVT.
Pharmanova Export PVT and Pharmanova Ghana Limited were disqualified because of double of complementary bidding by two related companies.
Both companies were represented by the same person at the tender opening.
Per the PPA findings, after one of the companies petitioned it, the product offered by Pharmanova India was not duly registered with the Food and Drugs Authority (FDA), but the MoH ignored it.
Apart from that, the MoH failed to evaluate the key clinical performance of the products presented by Pharmanova Export PVT and Pharmanova Ghana Limited.
Although, the handlers of the health sector are creating the impression that there were enough anti-snake serum in the country, the truth of the matter is that there is a shortage of the serum in the areas that are in need.
More On Wednesday!